Gentamicin exposure and sensorineural hearing loss in preterm infants

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Fuchs, Aline ^a   Zimmermann, Lara ^a   Graz, Myriam Bickle ^a   Cherpillod, Jacques ^a   Tolsa, Jean François ^a   Buclin, Thierry ^a   Giannoni, Eric ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXPOSURE; DRUG MONITORING; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; PERCEPTION DEAFNESS; PREMATURITY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; VERY LOW BIRTH WEIGHT; BLOOD; CHEMICALLY INDUCED; HEARING LOSS, SENSORINEURAL; INFANT NUTRITION DISORDERS; NEWBORN;

FEMALE; GENTAMICINS; HEARING LOSS, SENSORINEURAL; HUMANS; INCIDENCE; INFANT NUTRITION DISORDERS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RETROSPECTIVE STUDIES;

EID: 84978808478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158806     Document Type: Article

References (50)

1. Schlapbach LJ, Adams M, Proietti E, Aebischer M, Grunt S, Borradori-Tolsa C, et al. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC pediatrics. 2012; 12:198. doi: 10.1186/1471-2431-12-198 PMID: 23272671; PubMed Central PMCID: PMC3546845.
2. Serenius F, Kallen K, Blennow M, Ewald U, Fellman V, Holmstrom G, et al. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA. 2013; 309 (17):1810-20. doi: 10.1001/jama.2013.3786 PMID: 23632725.
3. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA. 2011; 306(21):2348-58. doi: 10.1001/jama.2011.1752 PMID: 22147379; PubMed Central PMCID: PMC3565238.
4. Robertson CM, Howarth TM, Bork DL, Dinu IA. Permanent bilateral sensory and neural hearing loss of children after neonatal intensive care because of extreme prematurity: a thirty-year study. Pediatrics. 2009; 123(5):e797-807. doi: 10.1542/peds.2008-2531 PMID: 19403472.
5. Davis NM, Doyle LW, Ford GW, Keir E, Michael J, Rickards AL, et al. Auditory function at 14 years of age of very-low-birthweight. Dev Med Child Neurol. 2001; 43(3):191-6. PMID: 11263690.
6. Norton SJ, Gorga MP, Widen JE, Folsom RC, Sininger Y, Cone-Wesson B, et al. Identification of neonatal hearing impairment: summary and recommendations. Ear and hearing. 2000; 21(5):529-35. PMID: 11059708.
7. Ari-Even Roth D, Hildesheimer M, Maayan-Metzger A, Muchnik C, Hamburger A, Mazkeret R, et al. Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening. Arch Dis Child Fetal Neonatal Ed. 2006; 91(4):F257-62. doi: 10.1136/adc. 2005.074476 PMID: 16531449; PubMed Central PMCID: PMC2672719.
8. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012; 307(3):275-82. doi: 10.1001/jama.2011.2024 PMID: 22253394.
9. Thiringer K, Kankkunen A, Liden G, Niklasson A. Perinatal risk factors in the aetiology of hearing loss in preschool children. Dev Med Child Neurol. 1984; 26(6):799-807. PMID: 6519362.
10. de Vries LS, Lary S, Dubowitz LM. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics. 1985; 76(3):351-4. PMID: 4034295.
11. Halpern J, Hosford-Dunn H, Malachowski N. Four factors that accurately predict hearing loss in "high risk" neonates. Ear and hearing. 1987; 8(1):21-5. PMID: 3030866.
12. Pettigrew AG, Edwards DA, Henderson-Smart DJ. Perinatal risk factors in preterm infants with moderate-to-profound hearing deficits. The Medical journal of Australia. 1988; 148(4):174-7. PMID: 3277017.
13. Brown DR, Watchko JF, Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-control study. Dev Med Child Neurol. 1991; 33(9):816-23. PMID: 1936634.
14. Walton JP, Hendricks-Munoz K. Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn. Journal of speech and hearing research. 1991; 34(6):1362-70. PMID: 1787718.
15. Borradori C, Fawer CL, Buclin T, Calame A. Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate. 1997; 71(1):1-10. PMID: 8996652.
16. Usami S, Abe S, Shinkawa H, Kimberling WJ. Sensorineural hearing loss caused by mitochondrial DNA mutations: special reference to the A1555G mutation. Journal of communication disorders. 1998; 31(5):423-34; quiz 34-5. PMID: 9777488.
17. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed. 2000; 82(2):F141-4. PMID: 10685988; PubMed Central PMCID: PMC1721061.
18. Aust G. Vestibulotoxicity and ototoxicity of gentamicin in newborns at risk. The international tinnitus journal. 2001; 7(1):27-9. PMID: 14964951.
19. Ertl T, Hadzsiev K, Vincze O, Pytel J, Szabo I, Sulyok E. Hyponatremia and sensorineural hearing loss in preterm infants. Biol Neonate. 2001; 79(2):109-12. 47076. PMID: 11223652.
20. Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics. 2005; 115 (6):1519-28. doi: 10.1542/peds.2004-0247 PMID: 15930212.
21. Robertson CM, Tyebkhan JM, Peliowski A, Etches PC, Cheung PY. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006; 95(2):214-23. doi: 10.1080/08035250500294098 PMID: 16449030.
22. Williams AL, van Drongelen W, Lasky RE. Noise in contemporary neonatal intensive care. The Journal of the Acoustical Society of America. 2007; 121(5 Pt1):2681-90. PMID: 17550168.
23. Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed. 2008; 93(6):F462-8. doi: 10.1136/adc. 2007.124214 PMID: 18941031; PubMed Central PMCID: PMC3597102.
24. Boghossian NS, Page GP, Bell EF, Stoll BJ, Murray JC, Cotten CM, et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr. 2013; 162(6):1120-4, 4 e1. doi: 10.1016/j.jpeds.2012.11.089 PMID: 23324523; PubMed Central PMCID: PMC3633723.
25. Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics. 2011; 128(2):e348-57. doi: 10.1542/peds.2010-3338 PMID: 21768312.
26. Polin RA, Committee on F, Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012; 129(5):1006-15. doi: 10.1542/peds.2012-0541 PMID: 22547779.
27. Stocker M, Berger C, McDougall J, Giannoni E, Taskforce for the Swiss Society of N, the Paediatric Infectious Disease Group of S. Recommendations for term and late preterm infants at risk for perinatal bacterial infection. Swiss Med Wkly. 2013; 143:w13873. doi: 10.4414/smw.2013.13873 PMID: 24089151.
28. Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. International journal of otolaryngology. 2011; 2011:937861. doi: 10.1155/2011/937861 PMID: 22121370; PubMed Central PMCID: PMC3202092.
29. Loughnan PM. Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe? Arch Dis Child Fetal Neonatal Ed. 2006; 91(2):F156. doi: 10.1136/adc.2005.084699 PMID: 16492962; PubMed Central PMCID: PMC2672682.
30. Bernard PA. Freedom from ototoxicity in aminoglycoside treated neonates: a mistaken notion. Laryngoscope. 1981; 91(12):1985-94. PMID: 7321720.
31. Hess M, Finckh-Kramer U, Bartsch M, Kewitz G, Versmold H, Gross M. Hearing screening in at-risk neonate cohort. International journal of pediatric otorhinolaryngology. 1998; 46(1-2):81-9. PMID: 10190708.
32. Setiabudy R, Suwento R, Rundjan L, Yasin FH, Louisa M, Dwijayanti A, et al. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates. International journal of clinical pharmacology and therapeutics. 2013; 51(5):401-6. doi: 10.5414/CP201833 PMID: 23557866.
33. Vella-Brincat JW, Begg EJ, Robertshawe BJ, Lynn AM, Borrie TL, Darlow BA. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology. 2011; 100 (2):186-93. doi: 10.1159/000324857 PMID: 21455009.
34. Fjalstad JW, Laukli E, van den Anker JN, Klingenberg C. High-dose gentamicin in newborn infants: is it safe? Eur J Pediatr. 2013. doi: 10.1007/s00431-013-2194-1 PMID: 24233331.
35. Rao SC, Srinivasjois R, Hagan R, Ahmed M. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2011;(11:):CD005091. doi: 10.1002/14651858.CD005091.pub3 PMID: 22071818.
36. Hille ET, van Straaten HI, Verkerk PH, Dutch NNHSWG. Prevalence and independent risk factors for hearing loss in NICU infants. Acta Paediatr. 2007; 96(8):1155-8. doi: 10.1111/j.1651-2227.2007. 00398.x PMID: 17655618.
37. Gopel W, Berkowski S, Preuss M, Ziegler A, Kuster H, Felderhoff-Muser U, et al. Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants. BMC pediatrics. 2014; 14:210. doi: 10.1186/1471-2431-14-210 PMID: 25155176; PubMed Central PMCID: PMC4236616.
38. American Academy of Pediatrics JCoIH. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007; 120(4):898-921. doi: 10.1542/peds.2007-2333 PMID: 17908777.
39. Metzger D, Pezier TF, Veraguth D. Evaluation of universal newborn hearing screening in Switzerland 2012 and follow-up data for Zurich. Swiss Med Wkly. 2013; 143:w13905. doi: 10.4414/smw.2013. 13905 PMID: 24338080.
40. Pirozzo S, Papinczak T, Glasziou P. Whispered voice test for screening for hearing impairment in adults and children: systematic review. Bmj. 2003; 327(7421):967. doi: 10.1136/bmj.327.7421.967 PMID: 14576249; PubMed Central PMCID: PMC259166.
41. Sawchuk RJ, Zaske DE, Cipolle RJ, Wargin WA, Strate RG. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clinical pharmacology and therapeutics. 1977; 21(3):362-9. Epub 1977/03/01. PMID: 837654.
42. Fuchs A, Guidi M, Giannoni E, Werner D, Buclin T, Widmer N, et al. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. British journal of clinical pharmacology. 2014; 78(5):1090-101. doi: 10.1111/bcp.12444 PMID: 24938850; PubMed Central PMCID: PMC4243884.
43. Levine M, Ensom MH. Post hoc power analysis: an idea whose time has passed? Pharmacotherapy. 2001; 21(4):405-9. PMID: 11310512.
44. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008; 358(7):700-8. doi: 10.1056/NEJMoa072788 PMID: 18272893.
45. Vellanki H, Antunes M, Locke RG, McGreevy T, Mackley A, Eubanks JJ, et al. Decreased incidence of pneumothorax in VLBW infants after increased monitoring of tidal volumes. Pediatrics. 2012; 130(5): e1352-8. doi: 10.1542/peds.2011-2611 PMID: 23045561.
46. El-Barbary MN, Ismail RI, Ibrahim AA. Gentamicin extended interval regimen and ototoxicity in neonates. International journal of pediatric otorhinolaryngology. 2015; 79(8):1294-8. doi: 10.1016/j.ijporl. 2015.05.036 PMID: 26071016.
47. Musiime GM, Seale AC, Moxon SG, Lawn JE. Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: Systematic Review. Trop Med Int Health. 2015; 20(12):1593-606. doi: 10.1111/tmi.12608 PMID: 26426298.
48. Jing W, Zongjie H, Denggang F, Na H, Bin Z, Aifen Z, et al. Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis. Journal of medical genetics. 2015; 52(2):95-103. doi: 10.1136/jmedgenet-2014-102753 PMID: 25515069.
49. Ealy M, Lynch KA, Meyer NC, Smith RJ. The prevalence of mitochondrial mutations associated with aminoglycoside-induced sensorineural hearing loss in an NICU population. Laryngoscope. 2011; 121 (6):1184-6. doi: 10.1002/lary.21778 PMID: 21495045.
50. Bitner-Glindzicz M, Rahman S, Chant K, Marlow N. Gentamicin, genetic variation and deafness in preterm children. BMC pediatrics. 2014; 14:66. doi: 10.1186/1471-2431-14-66 PMID: 24593698; PubMed Central PMCID: PMCPMC3984755.